Press Releases/IR - Page 1 | TalkMarkets
All Posts > Content under Press Releases/IR
1 to 16 of 450 Posts
1 2 3 ... 29
Herbalife Reports Fourth Quarter Reported Net Sales Growth Of 4.6% And Reiterates Growth Projections For 2018
Article By: Business Wire
Thursday, February 22, 2018 5:36 PM EST
Herbalife Ltd. reports results for the fourth quarter and full year ended December 31, 2017.
In this article: HLF
Read
OTEZLA (Apremilast) Phase III Data Showed Significant Improvements In Patients With Active Behçet’s Disease With Oral Ulcers
Article By: Business Wire
Saturday, February 17, 2018 4:15 PM EST
Trial demonstrated statistically significant reductions in oral ulcers with apremilast 30mg versus placebo through week 12. Significant improvements in key secondary endpoints, including oral ulcer pain, overall disease activity and quality of life.
In this article: CELG
Read
WisdomTree Announces Changes To ETF Family
Article By: NASDAQ GlobeNewswire
Friday, February 16, 2018 4:09 PM EST
WisdomTree (WETF​), an exchange-traded fund and exchange-traded product sponsor and asset manager, today announced plans to close and liquidate nine of its ETFs. The Funds will no longer accept creation orders after Friday, March 16, 2018.
In this article: WETF, DXJH, DXUS, DXJR, DXPS, DXJC, EMSD
Read
Catalyst Biosciences Announces Closing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, February 15, 2018 5:36 PM EST
Catalyst Biosciences, today announced the closing of an underwritten public offering of 3,382,352 shares of its common stock, offered at a price of $34.00 per share to the public.
In this article: CBIO
Read
Inpixon Prices $18M Public Offering
Article By: NASDAQ GlobeNewswire
Thursday, February 15, 2018 11:58 AM EST
INPIXON today announced the pricing of a public offering with anticipated gross proceeds of approximately $18 million, before deducting placement agent fees and other offering expenses.
In this article: INPX
Read
Catalyst Biosciences Announces The Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, February 13, 2018 12:50 PM EST
Catalyst Biosciences, Inc. today announced the pricing of an underwritten public offering of 2,941,176 shares of its common stock, offered at a price of $34.00 per share to the public.
In this article: CBIO
Read
Litecoin Bullish Despite Potentially Scammy Fork Rumors
Article By: Kiana Danial
Tuesday, February 13, 2018 12:19 AM EST
Is Litecoin Cash is moving towards the release of a new cryptocurrency that will be born from a hard fork of Litecoin?
In this article: LTC-X
Read
Pacific Biosciences Of California, Inc. Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Monday, February 12, 2018 5:44 PM EST
Pacific Biosciences of California, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
In this article: PACB
Read
Daseke, Inc. Announces Follow-On Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Monday, February 12, 2018 11:51 AM EST
Daseke, Inc. today announced the commencement of an underwritten public offering of 7,420,000 shares of its common stock by the Company and 80,000 shares of its common stock by one of the Company’s stockholders.
In this article: DSKE
Read
Gemphire Announces Pricing Of $22 Million Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, February 8, 2018 12:42 PM EST
Gemphire Therapeutics Inc. today announced the pricing of its previously announced underwritten public offering of 3,142,858 shares of its common stock at a public offering price of $7.00 per share.
In this article: GEMP
Read
BiondVax And European UNISEC Consortium To Host Universal Flu Vaccine Conference
Article By: PR Newswire
Thursday, February 8, 2018 10:40 AM EST
BiondVax Pharmaceuticals Ltd. developer of a Universal Flu Vaccine candidate currently in preparation for a Phase 3 clinical trial, and the European UNISEC consortium announced today they will co-host the Annual UNISEC Consortium Meeting.
In this article: BVXV
Read
Nasdaq Reports Fourth Quarter And Full Year 2017 Results; Delivers Strong Revenue And Income Growth
Article By: NASDAQ GlobeNewswire
Wednesday, January 31, 2018 8:57 AM EST
2017 net revenues were $2,428 million, an increase of 7% compared to 2016. Subscription and recurring revenues increased 7% in 2017 compared to the prior year, and represented 76% of total net revenues.
In this article: NDAQ
Read
Fidus Investment Corporation Announces Public Offering Of Notes
Article By: NASDAQ GlobeNewswire
Tuesday, January 30, 2018 11:26 AM EST
Fidus Investment Corporation today announced the commencement of a registered public offering of unsecured notes due 2023 (the “Notes”), subject to market and other conditions.
In this article: FDUS
Read
Iovance Biotherapeutics, Inc. Announces Closing Of $172.5 Million Common Stock Public Offering
Article By: NASDAQ GlobeNewswire
Monday, January 29, 2018 11:38 PM EST
Iovance Biotherapeutics, Inc. today announced the closing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $11.50 per share.
Read
First Majestic Completes US$150 Million Convertible Senior Notes Offering
Article By: NASDAQ GlobeNewswire
Monday, January 29, 2018 12:09 PM EST
First Majestic Silver Corp. announced today the closing of its previously announced offering of US$150 million aggregate principal amount of 1.875% unsecured convertible senior notes due 2023.
In this article: AG
Read
Iovance Biotherapeutics, Inc. Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, January 25, 2018 8:36 AM EST
Iovance Biotherapeutics, Inc. today announced the pricing of an underwritten public offering of 13,043,479 shares of its common stock at a public offering price of $11.50 per share.
In this article: IOVA
Read
1 to 16 of 450 Posts
1 2 3 ... 29